European equities traded in the US as American depositary receipts were higher Wednesday morning, rising 0.93% to 1,436.34 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and pharmaceutical company Ascendis Pharma (ASND), which rose 3.1% and 2.8% respectively. They were followed by biotech firm BioNTech (BNTX) and 3D printer company Materialise (MTLS), which were up 1.8% and 1.6% respectively.
The decliners from continental Europe were led by biopharmaceutical company Genfit (GNFT) and hotel booking site trivago (TRVG), which lost 2.1% and 1.8% respectively. They were followed by internet browser company Opera (OPRA) and biopharmaceutical company Calliditas Therapeutics (CALT), which fell 1.6% and 1.4% respectively.
From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Amarin (AMRN), which climbed 8.1% and 5.2% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and Adaptimmune Therapeutics (ADAP), which were up 5.1% and 4% respectively.
The decliners from the UK and Ireland were led by utilities company National Grid (NGG) and financial services firm Lloyds Banking Group (LYG), which fell 2.3% and 2.1% respectively. They were followed by biopharmaceutical firm Biodexa Pharmaceuticals (BDRX) and pharmaceutical company Avadel Pharmaceuticals (AVDL), which were down 2% and 1.9% respectively.
Comments